The superoxide-generating neutrophil NADPH oxidase can be activated in cell-free reconstitution systems by several agonists, most notably arachidonic acid and the detergent sodium dodecyl sulfate. In this study, we show that both phosphatidic acids and diacylglycerols can serve separately as potent, physiologic activators of NADPH oxidase in a cell-free system. Stimulation of superoxide generation by these lipids was dependent upon both Mg 2؉ and agonist concentration. Activation of NADPH oxidase by phosphatidic acids did not appear to require their conversion to corresponding diacylglycerols by phosphatidate phosphohydrolase, since diacylglycerols were much slower than phosphatidic acids to activate the system and required the presence of ATP. Stimulation of the oxidase by dioctanoylglycerol proved to be by a means other than the activation of protein kinase C. Instead, dioctanoylglycerol was converted to dioctanoylphosphatidic acid by an endogenous diacylglycerol kinase present in the cell-free reaction system. This conversion was sensitive to the diacylglycerol kinase inhibitor R59949 and explains the markedly slower kinetics of activation and the novel ATP requirement seen with dioctanoylglycerol. The level of dioctanoylphosphatidic acid formed was suboptimal for NADPH oxidase activation but could synergize with the unmetabolized dioctanoylglycerol to activate superoxide generation.
In response to a variety of stimuli, the human neutrophil is capable of the potent and sustained production of superoxide anion (O 2 . ). This is achieved through the single-electron reduction of molecular oxygen in a reaction catalyzed by a multicomponent NADPH oxidase system, thus: NADPH ϩ 2O 2 3 NADP ϩ ϩ 2O 2 . ϩ H ϩ . Once formed, O 2 . is rapidly converted to a battery of reactive oxygen intermediates, including HOCl and H 2 O 2 , which then serve as important microbicidal agents of the phagosome. The phagocyte NADPH oxidase is composed of at least five unique protein components, two of which, gp91 phox and p22 phox , are integral to the plasma and specific granule membranes and together form the heterodimeric flavocytochrome b 558 (1) (2) (3) . Three other components, p40
phox , p47 phox , and p67 phox exist in a high molecular mass complex in the cytosol of resting neutrophils (4 -9) . In addition, the small GTP-binding protein Rac (Rac1 or Rac2) is required for NADPH oxidase activation (10, 11) . The formation of a fully active, catalytic complex requires association of the cytosolic oxidase components with the flavocytochrome at the plasma or phagolysosomal membrane (7, 12, 13) .
Activation of NADPH oxidase occurs when physiological stimuli bind to cell surface receptors, thereby triggering signal transduction events and the generation of lipid-derived second messenger molecules. Key elements of the lipid conversion pathways most likely to be involved are summarized in Fig. 1 . (For a comprehensive review of these and related pathways see Ref.
14.) For example, following binding of the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (fMLP) 1 to its receptor, diacylglycerol (DAG) and inositol trisphosphate are formed by the action of a phospholipase C upon phosphatidylinositol 4,5-bisphosphate (15) (16) (17) . Together, DAG and inositol trisphosphate (via the mobilization of intracellular Ca 2ϩ ) can activate protein kinase C (PKC), a candidate protein kinase for the multisite phosphorylation of p47 phox (18, 19) . DAG also can be converted to phosphatidic acid (PA) by the action of a stimulus-responsive, translocatable diacylglycerol kinase (DGK) (20) . An alternative pathway of PA/DAG production in response to fMLP involves the activation of a phospholipase D, which catalyzes the breakdown of phosphatidylcholine into choline and PA (21) (22) (23) (24) (25) . PA can be converted to DAG via the action of a phosphatidic acid phosphohydrolase (26, 27) or to lyso-PA and arachidonic acid by phospholipase A 2 (14) .
To facilitate the study of phagocyte NADPH oxidase, cell-free systems were devised that contained cytosolic and plasma membrane fractions from unstimulated cells. In these assay systems, O 2 . generation is initiated by the addition of an anionic amphiphile, such as arachidonate or SDS (28 -32) . SDS is clearly a nonphysiologic stimulus, and arachidonate is active in the cell-free system only at concentrations unattainable in intact, stimulated neutrophils (31, 33) . While there is a wealth of data from studies with intact (34 -43) and electropermeabi-lized (44, 45) neutrophils implicating PA (and to some extent DAG) in NADPH oxidase priming and activation (reviewed in Ref. 46) , there has been only limited success at stimulating cell-free oxidase systems with either of these lipids. Two studies have reported the induction of low levels of O 2 . production with PA (47, 48) . In Ref. 48 , utilizing pig neutrophil membranes, activity was independent of cytosolic oxidase components and added nucleotides, implying a direct activation of the flavocytochrome, similar to the more recent studies of Koshkin and Pick (49) . DAG has been shown to synergize with both SDS (50) and PA (51) in the cell-free activation of NADPH oxidase.
In contrast to other cell-free activators (e.g. arachidonic acid, SDS), which have very short lag times (1-3 min), it has been reported that synergistic activation by PA/DAG requires 30 -60 min to reach maximal O 2 .
-generating activity and that their effect is dependent on the activity of a novel protein kinase (52, 53) . In this report, we describe for the first time the potent activation of the neutrophil NADPH oxidase in a cell-free system by physiologically attainable concentrations of PA or DAG, in the absence of other agonists. The rates of O 2 . production achieved were similar to those induced by SDS and arachidonate and were equivalent to rates observed with intact neutrophils. Based on kinetics, nucleotide requirement, and susceptibility to inhibitors, we propose that activation by DAG in this system is dependent upon its conversion to PA. Our results are in accord with intact cell studies, in that they point to PAs as physiologic activators of O 2 . production, coupling the neutrophil's signal transduction pathways to NADPH oxidase activation.
EXPERIMENTAL PROCEDURES
Materials-Phosphatidic acids and diacylglycerols were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL). [␥-
32 P]ATP (6000 Ci/ mmol) was obtained from NEN Life Science Products. Escherichia coli sn-1,2-diacylglycerol kinase and the diacylglycerol kinase inhibitor 3-(2-(4-(bis-[4-fluorophenyl]-methylene)-1-piperidinyl)-ethyl)-2,3-dihydro-2-thioxo-4(1H)-quinazolinone (R59949) were purchased from Calbiochem. All other chemicals and reagents were of the finest grade commercially available and were procured from sources previously described (32) .
Preparation of Neutrophils-Neutrophils were harvested by leukapheresis of normal donors and chronic granulomatous disease patients with their informed consent. Donors were given 4 mg of dexamethasone orally 12 and 2 h prior to the procedure to increase neutrophil yields. The properties of subcellular fractions prepared from the purified neutrophils of these donors were indistinguishable from those derived from individuals not treated with dexamethasone (54) . Purification of neutrophils from the leukapheresis product was accomplished as detailed earlier (55) . All stages of neutrophil isolation were conducted at 4°C.
Neutrophil Fractionation-Partially purified membrane and cytosol fractions were produced by the disruption of unstimulated neutrophils by nitrogen cavitation and the subsequent fractionation of this cavitate as previously reported (32, (55) (56) (57) . Cytosolic fractions were prepared at 9.0 ϫ 10 7 cell equivalents (cell eq)/ml (approximately 2 mg of protein/ ml) in "relax buffer" (10 mM PIPES, 100 mM KCl, 3.5 mM MgCl 2 , 3 mM NaCl, pH 7.3), supplemented with 1 mM ATP and 1.25 mM EGTA. Membrane fractions were brought to a final concentration of 1.25 ϫ 10 9 cell eq/ml (approximately 5 mg of protein/ml) in 5 mM PIPES, 50 mM KCl, 1.75 mM MgCl 2 , 1.5 mM NaCl, 0.5 mM ATP, 0.63 mM EGTA, 0.34 M sucrose, pH 7.3. All purified cell fractions were stored at Ϫ80°C and thawed just prior to use.
Dialysis and Charcoal Treatment of Purified Neutrophil FractionsNeutrophil cytosolic fractions (10 ml) were dialyzed against three successive 6-h changes (3000 ml each) of relax buffer without MgCl 2 at 4°C. Charcoal treatment of dialyzed cytosols and deoxycholate-solubilized membranes was performed as described in Ref. 58 .
Preparation of Lipids-Diacylglycerols and phosphatidic acids, shipped in chloroform on dry ice, were diluted to 10 mM with chloroform and stored in borosilicate glass tubes at Ϫ20°C in 0.3-ml aliquots. Solutions used to activate the cell-free system were made fresh daily. For the diacylglycerols, an aliquot was removed, and the chloroform was evaporated with a stream of N 2 gas. Me 2 SO was then added to restore the concentration to 10 mM. Subsequent dilutions were accomplished in H 2 O, maintaining a final volume ratio of 1.5:8.5 (Me 2 SO: H 2 O). A 10-l aliquot of diacylglycerols diluted in this fashion was added to 140 l of reaction mixture to initiate cell-free NADPH oxidase activity.
Phosphatidic acid aliquots were similarly evaporated with N 2 , and subsequently brought to 10 mM with H 2 O. These solutions were warmed to 37°C and gently agitated in a sonicating water bath (Heat SystemsUltrasonics Inc., Plainview, NY) until opalescent. Further dilutions were then made in H 2 O. Again, 10 l of agonist was added to reaction mixtures (140 l) to initiate activity.
Cell-free Assay of NADPH Oxidase Activation-NADPH oxidase activation was measured in a cell-free system as described previously (54), utilizing membrane and cytosol fractions purified from unstimulated neutrophils. Membranes were solubilized in deoxycholate before use (54) . All assays were carried out at 25°C, since the use of higher temperatures severely limits oxidase activity in this and similar systems (52) . Reactions (150-l total volume) were performed in relax buffer containing an optimal concentration of MgCl 2 for the agonist used, plus cytochrome c (0.1 mM) and NADPH (0.16 mM). After activation by a variety of stimuli, superoxide production was determined by measuring the superoxide dismutase-inhibitable reduction of cytochrome c at 550 nm in a ThermoMax ® kinetic microplate reader (Molecular Devices Corp., Menlo Park, CA), using a 550 Ϯ 1-nm filter. Maximum reaction velocities were calculated using SoftMax ® kinetic analysis software (version 2.01, Molecular Devices). Control wells containing superoxide dismutase (60 g/ml) were run simultaneously with each test reaction, and maximum velocity measurements from these controls were subtracted from test well values to provide the superoxide dismutase-inhibitable rate of cytochrome c reduction for each reaction. This rate of maximum absorbance change was converted to nmol of O 2 . /min as detailed earlier for this 550-nm filter (59) .
Single reaction kinetic traces were produced using a Kontron Uvikon ® 810 dual-beam spectrophotometer (Kontron Electronics, Inc., Redwood City, CA). These reaction mixtures (0.75 ml) were essentially identical to those described above and contained 9.9 ϫ 10 6 cell eq of cytosol and 3.13 ϫ 10 6 cell eq of deoxycholate-solubilized membranes. For all cell-free assays performed, complete reaction mixtures were allowed to incubate for 3 min at 25°C prior to the addition of stimulus. In reactions employing dialyzed cytosol, exogenous nucleotides were added to reconstitute oxidase activity. For all such assays, GTP␥S was added to a final concentration of 10 M; reactions activated with diacylglycerols also required supplemental ATP (100 M).
Cell-free NADPH oxidase assays utilizing membrane vesicles required slightly different conditions for optimal activity. Deoxycholate was completely eliminated from these reaction mixtures (150 l), and the membrane vesicles required a brief pretreatment at 37°C with the activating lipid. Specifically, the plasma membrane vesicles (diluted to 2.0 ϫ 10 8 /ml with relax buffer) were incubated for 5 min at 37°C in the presence of a given concentration of lipid activator. This mixture was then allowed to cool at room temperature for 3 min prior to addition to the assay well. Upon addition, a further amount of the lipid activating species was also added to the total reaction mixture to maintain the concentration present during the preincubation period. Reactions were then followed at 25°C in the kinetic microplate reader, as outlined above.
Determination of Phospholipid Content-Complete oxidase reaction mixtures (0.6 ml) supplemented with 41.4 Ci of [␥-
32 P]ATP were activated with 70 M dioctanoylglycerol. After 15 min, 0.5-ml aliquots were transferred to 3 ml of chloroform/methanol (1:2, v/v) containing the antioxidant butylated hydroxytoluene (1 mg/ml). These extraction mixtures were vortexed and allowed to incubate in 15-ml polypropylene tubes for 15 min at 25°C. CHCl 3 (2.1 ml) was added, followed by 2.1 ml of 2.4 N HCl. After thorough mixing, samples were centrifuged 6 min at 300 ϫ g to clarify the solvent interface. The lower (organic) phase was then collected, and the upper (aqueous) phase was washed twice with 2.1 ml of CHCl 3 . All three organic phases were then pooled and stored on dry ice until analyzed (less than 24 h). These samples were then brought to room temperature, dried under N 2 , and resuspended in 2 ml of water-saturated CHCl 3 . Aliquots were taken for scintillation counting, and the remainder was reconcentrated under N 2 , resuspended in 90 l of water-saturated CHCl 3 , and spotted on oxalate-impregnated thin layer chromatography (TLC) plates (silica gel 60; EM Science, Gibbstown, NJ). Phospholipids were chromatographed as described elsewhere (60, 61) . Lipids were visualized by iodine staining and autoradiography, and the radioactivity in phospholipids was quantitated using an AMBIS ␤-scanning system (AMBIS Systems, Inc., San Diego, CA) (60, 61 Data Analysis and Presentation-Maximum reaction velocities were directly measured from the linear portion of kinetic traces obtained on the dual-beam spectrophotometer and were determined as detailed above for assays run in microplate format. Variances shown represent the mean Ϯ one S.D. Error bars (Figs. 2, 4B, and 5) are one S.D. in length and are smaller than the symbol size if not depicted. AMBIS ␤-scanning data were evaluated using AMBIS QuantProbe ® (version 3.02) image analysis software. Where statistical significance is reported, the p values given were generated using an unpaired t test (SigmaStat 2.0, SPSS Inc., Chicago, IL).
RESULTS
Superoxide Generation Can Be Activated in a Cell-free System by PA and DAG-In an attempt to provide a link between the elevation of intracellular DAG and PA and the activation of NADPH oxidase in response to various stimuli in the intact cell (see the Introduction), we tested the ability of these lipids to activate the enzyme in a cell-free system. Fig. 2 demonstrates that dioctanoylglycerol and dioctanoyl-and dilauroylphosphatidic acids can all serve as potent, singular activators of O 2 .
generation by NADPH oxidase when Mg 2ϩ and agonist concentrations are carefully controlled. The Mg 2ϩ dependence of SDS, DAG, and PA agonists is shown in Fig. 2 , A and C. Dioctanoylglycerol demonstrated a profile of Mg 2ϩ sensitivity similar to that of SDS, achieving maximal stimulation of O 2 . production in the presence of 3 mM Mg 2ϩ (final concentration). In our initial experiments with the two PA species, using our standard assay conditions (6 mM Mg 2ϩ ), activation of the cell-free system was virtually undetectable. However, since stimulation of O 2 . production by arachidonic acid (56) and SDS (Ref. 57 and this study) was clearly sensitive to Mg 2ϩ concentration, the PAs were retested over a range of concentrations of the divalent cation. Dioctanoylphosphatidic acid showed a profile similar to that of dioctanoylglycerol, maximally activating the system at 1 mM Mg 2ϩ . Dilauroylphosphatidic acid, on the other hand, exhibited a significantly lower and much more sensitive requirement for Mg 2ϩ , as concentrations above 100 M proved inhibitory.
Next, we investigated the dependence of enzyme activity on the concentration of each agonist at optimal Mg 2ϩ concentrations (Fig. 2, B and D) . Activation of the oxidase by SDS was highly concentration-dependent, with a sharp optimum at 40 M. Conversely, stimulation by dioctanoylglycerol was fairly constant over the range 20 -100 M. It is important to note that in our hands only highly purified dioctanoylglycerol from Avanti Polar Lipids was reproducibly potent as an activator of NADPH oxidase, and it proved necessary to test each lot received for optimal stimulus concentration. Phosphatidic acids obtained from Avanti were free from lot-to-lot variation and exhibited very reproducible dose optima: 100 M for dilauroylphosphatidic acid and 75 M for dioctanoylphosphatidic acid (Fig. 2D) .
Kinetics of NADPH Oxidase Activation by PA and DAG-The lipid second messengers PA and DAG activated NADPH oxidase with strikingly different kinetics. As shown in Fig. 3 , when the cell-free system was stimulated with dioctanoylphosphatidic acid, the lag between the addition of the stimulus and the generation of O 2 . at a maximal rate was only marginally longer than with SDS. In contrast, dioctanoylglycerol required an extremely long lag time, commonly from 7 to 10 min, before maximal rates of O 2 . production were reached. Only the careful maintenance of Mg 2ϩ concentration, agonist optimum, and (for DAG) reaction time course allowed us to detect the full potency of these lipids as activators of the cell-free NADPH oxidase.
PA and DAG Have Different Purine Nucleotide Requirements-The results of experiments to determine the absolute requirements for NADPH oxidase activation by dioctanoylglycerol and dilauroylphosphatidic, with SDS as a comparison, are summarized in Table I . As shown previously with SDS (32), stimulation of O 2 . production by either the PA or DAG was dependent upon the presence of neutrophil cytosolic fraction (containing p40 phox , p47 phox , p67 phox , and Rac), neutrophil plasma membrane extract (containing the flavocytochrome b 558 heterodimer), and exogenous NADPH. No activation was detected in the absence of stimuli. When the cytosol used in cell-free assays is extensively dialyzed to remove endogenous nucleotides (see "Experimental Procedures"), the specific nucleotide cofactor requirements of the enzyme are revealed (58) . Using this technique, we and others (58, 62) have shown that activation by SDS was absolutely dependent upon the presence of GTP (or GTP␥S) and that O 2 . production detected in the presence of exogenous ATP only (i.e. no guanine nucleotide added) was due to the conversion of the remaining trace amounts of GDP in the dialyzed cytosol to GTP (58) . If both ATP and GTP were omitted from the assay, no O 2 . production was seen (Ref. 58 and Table I ). As evident from Table I , activation of NADPH oxidase by dilauroylphosphatidic acid showed an analogous pattern of GTP dependence, with activity abolished only in the absence of both ATP and GTP. Conversely, stimulation by dioctanoylglycerol required both ATP and GTP. The ATP supplied (100 M optimum concentration, data not shown) had to be in hydrolyzable form; substitution of AppNHp for ATP in the assay system did not support oxidase activation by dioctanoylglycerol but did permit O 2 . production with SDS, indicating that it is not inhibitory for the enzyme. While ATP was not required for activation by PA, omission of ATP from this reaction did cause a significant reduction in O 2 . production. Activation of NADPH oxidase by all agonists tested was absolutely dependent upon the presence of p47 phox , p67 phox , and membrane extracts containing flavocytochrome b 558 , as demonstrated by substituting cytosolic and plasma membrane fractions derived from appropriate chronic granulomatous disease patients in these assays.
Comparison of PAs and DAGs Containing Fatty Acids of Different Chain
Length-A variety of other forms of PA and DAG also proved capable of stimulating the phagocyte NADPH oxidase, as shown in Table II . Two separate cell-free assay systems were used. The first employed deoxycholate-solubilized membranes as the source of plasma membrane-associated oxidase components, while the second used purified plasma membrane vesicles. All lipids tested were assayed at optimal FIG. 3 . Single reaction kinetic traces. Change in A 550 was followed with respect to time in a dual beam spectrophotometer using 0.75-ml cell-free oxidase assays as described under "Experimental Procedures." These reactions contained 9.9 ϫ 10 6 cell eq of dialyzed cytosol, 3.13 ϫ 10 6 cell eq of deoxycholate-solubilized membranes, and either 3 mM MgCl 2 (SDS, DAG) or 1 mM MgCl 2 (PA). Oxidase activation by dioctanoylglycerol in the presence of exogenous diacylglycerol kinase (the DAG ϩ DGK kinetic trace) was accomplished in a reaction mixture that included 0.16 units of E. coli diacylglycerol kinase dissolved in 15 l of a buffer containing 10 mM phosphate buffer, pH 7.0, 20% (v/v) glycerol, and 2 mM ␤-mercaptoethanol. An identical volume of this buffer was included in the PA and DAG reactions and had no effect on the observed kinetics. All reactions were allowed to preincubate for 3 min at 25°C prior to the addition of agonist (arrow). 
Activation of NADPH Oxidase by PA or DAG
Mg 2ϩ and agonist concentrations. A series of phosphatidic acids were able to stimulate significant O 2 . production in assays utilizing deoxycholate-solubilized membranes. Each active species demonstrated specific concentration dependence, with lyso-oleoylphosphatidic acid activating the oxidase at an optimal concentration of only 10 M. Dioleoylglycerol was compared with dioctanoylglycerol as an activator of the oxidase and found to be only minimally active. No other synthetic diacylglycerides were tested. In the system employing membrane vesicles (and consequently free of solubilizing detergent), oxidase activation was less robust in assays activated by the longer fatty acyl side chain phosphatidic acids. No O 2 . production was seen when lyso-oleoylphosphatidic acid was used as stimulus. Dilauroylphosphatidic acid was fully active in this system, supporting O 2 . production comparable with that seen in the presence of deoxycholate-solubilized membranes. Dioctanoylglycerol activated the oxidase in the presence of membrane vesicles at an optimal concentration of only 10 M, but the activity was only one-sixth that seen with solubilized membrane extracts. Again, this stimulation of O 2 . production by DAG was ATP-dependent (data not shown).
PA-mediated Activation Is Not Dependent on Conversion to DAG-Activation
of NADPH oxidase by phosphatidic acid species could depend upon the conversion of PA to DAG by a phosphatidic acid phosphohydrolase. Although this possibility seemed unlikely, considering the different kinetics and nucleotide requirements of the two stimuli, we nevertheless addressed it experimentally by performing cell-free assays in the presence of increasing amounts of propranolol, an inhibitor of PA phosphohydrolase (24, 63, 64) . We observed a dose-dependent inhibition of O 2 . production by propranolol not only with dioctanoylphosphatidic acid as the stimulus but also with SDS and dioctanoylglycerol, suggesting a nonspecific effect of the inhibitor with these activating agents. At 300 M propranolol, the levels of inhibition were 72.7 Ϯ 24.0% (n ϭ 3), 84.4 Ϯ 16.7% (n ϭ 6), and 73.1 Ϯ 19.1% (n ϭ 4) with SDS, dioctanoylglycerol, and dioctanoylphosphatidic acid, respectively. However, activation of NADPH oxidase by dilauroylphosphatidic acid was unaffected by up to 300 M propranolol, providing good evidence against a role for phosphatidate phosphohydrolase activity in PA-mediated NADPH oxidase activation. production in this assay system. Third, when two inhibitors of PKC, calphostin C and chelerythrin chloride (65, 66) , were tested at 300 nM and 1 M, respectively, neither was able to inhibit NADPH oxidase activation by dioctanoylglycerol (data not shown). Activation by DAG Depends upon Diacylglycerol Kinase-An alternative explanation for the ATP requirement in DAG activation of the oxidase is suggested by Fig. 1 , in which it can be seen that DGK can play a central role in lipid remodeling in the neutrophil. DGK phosphorylates DAGs to their corresponding PAs, utilizing ATP as the high energy phosphate donor. Conversion of DAG to an active form by DGK could also explain the extremely long lag time between the addition of dioctanoylglycerol and the detection of maximum rates of O 2 . production.
When cell-free reactions were performed in the presence of additional, exogenous DGK (Fig. 3 ) the lag time was consistently and significantly decreased, suggesting that this pathway is involved in NADPH oxidase activation by DAG and that DGK is limiting in the normal reaction mixture. We reasoned that if dioctanoylglycerol activates the oxidase via DGK-mediated conversion to dioctanoylphosphatidic acid, then 1) thin layer chromatographic analysis of the lipid species in reaction mixtures should reveal the phosphorylation of DAG to form PA and 2) inhibition of endogenous DGK should decrease both O 2 . production and PA formation. We therefore measured the formation of [ 32 P]dioctanoylphosphatidic acid by following the incorporation of 32 P (from [␥-32 P]ATP) into dioctanoylglycerol in oxidase reactions activated with this DAG, in the presence and absence of R59949, a DGK inhibitor (67) . As shown in Fig. 4A , in the absence of stimulus there was neither O 2 . generation nor formation of 32 P-labeled dioctanoylphosphatidic acid over a 15-min incubation period. Activation of the system by dioctanoylglycerol led to the generation of O 2 . as well as a concomitant accumulation of This apparent conversion of only ϳ25% of the available dioctanoylglycerol mass to dioctanoylphosphatidic acid, resulting in a final PA concentration substantially below the optimal required for activation (75 M; see Fig. 2D ), called into question the role of PA in activating the oxidase. We therefore tested the ability of suboptimal concentrations of two PAs to activate NADPH oxidase in the presence and absence of an optimal concentration of their corresponding DAGs. Fig. 5 depicts the synergistic activation of the cell-free system by suboptimal concentrations of dioctanoylphosphatidic acid in the presence of 70 M dioctanoylglycerol. Charcoal-treated deoxycholate-solubilized membranes and charcoal-treated dialyzed cytosol were used in these assays to ensure maximal removal of nucleotide cofactors. ATP was omitted from reactions to ensure that the diglyceride itself would not activate the oxidase, and GTP␥S (10 M) was included to permit stimulation of the oxidase by dioctanoylphosphatidic acid. Under these conditions, the ability of low concentrations of dioctanoylphosphatidic acid to synergize with the larger mass of inactive dioctanoylglycerol was most apparent at 16 and 40 M PA, where the increase in activity over basal levels (no diglyceride present) was highly statistically significant (p ϭ 0.011 and p ϭ 0.007, respectively). Conversely, dioleoylphosphatidic acid and dioleoylglycerol failed to show such cooperativity: the addition of 100 M dioleoylglycerol only served to slightly inhibit oxidase activation by 2-100 M dioleoylphosphatidic acid (data not shown). Similarly, dioleoylglycerol was incapable of substituting for dioctanoylglycerol as a synergist with dioctanoylphosphatidic acid (data not shown). The inability of dioleoylglycerol to effectively synergize with PAs may account for its low activity as an agonist in this system (see Table II ). . production in the cell-free system was compared with its ability to block conversion of dioctanoylglycerol to dioctanoylphosphatidic acid. In A, the accumulation of 32 P-labeled dioctanoylphosphatidic acid was measured as described under "Experimental Procedures." Cell-free oxidase reactions (0.6 ml) contained 7.92 ϫ 10 6 cell eq of dialyzed cytosol, 2.5 ϫ 10 6 cell eq of deoxycholate-solubilized membranes, 3 mM MgCl 2 , 10 M GTP␥S, 100 M ATP, and 0, 1, or 50 M R59949. [␥-
32 P]ATP (41.4 Ci) was added to each reaction, and the mixtures were allowed to preincubate at 25°C for 3 min. As a control, no diglyceride was added to one of the reactions in order to track nonspecific incorporation of radioactive label (no stimulus). For each of the remaining reactions, dioctanoylglycerol was added to 70 M, and the mixture was allowed to incubate for 15 min at room temperature. Reactions were stopped by extraction of lipids in chloroform/methanol, and these extracts were then analyzed by TLC for phospholipid content. Accumulation of [ 32 P]dioctanoylphosphatidic acid was quantified on an AMBIS ␤-scanning system and is plotted (open bars) in thousands of cpm above background. Shaded bars depict O 2 . production as measured in duplicate reactions by the cell-free NADPH oxidase assay described in Fig. 3 . B shows the inhibitory effect of increasing concentrations of R59949 on O 2 . production by DAG. 
DISCUSSION
Phosphatidic acids and diglycerides constitute important biological messengers, linking the signal transduction apparatus to important effector systems in many different cell types. In this work, we describe for the first time the ability of PAs or DAGs to serve as potent, singular activators of the neutrophil NADPH oxidase in a cell-free system, in the absence of other exogenous stimuli or synergists. These results therefore provide a causal link between the activation of the enzyme and the rise of intracellular DAG and PA observed in the intact cell in response to various stimuli.
By carefully controlling Mg 2ϩ and agonist concentrations, we were able to achieve vigorous activation of cell-free O 2 . generation by the phospholipids studied. This sensitivity to Mg 2ϩ concentration is most likely due to the interaction of the divalent cation with the lipid structures involved in activation, including plasma membrane vesicles, detergent-solubilized plasma membranes, and the lipid-activating species themselves. Micellar packaging of the stimulus may also play a role in the cell-free activation of the oxidase, and both agonist and Mg 2ϩ concentrations would influence this effect. While PA has been shown to activate NADPH oxidase in both whole and electropermeabilized human neutrophils and to stimulate cell-free oxidase systems under specific conditions (see the Introduction for references), our findings are unique in demonstrating the ability of PA to activate directly (and without a synergistic agent) the generation of O 2 . in a cell-free reaction requiring all of the known oxidase components. Previous work has implicated the action of PA upon a novel protein kinase, capable of phosphorylating p47 phox , as the means by which the phospholipid (in the presence of DAG) stimulates the cell-free enzyme (52, 53) . This system required ATP, and a 30 -60-min preincubation of the reaction mixture with the lipid activators, prior to the addition of substrate, to achieve maximal rates of O 2 . production (51, 52) . In contrast, in the NADPH oxidase system we describe here, within 3 min of its addition PA was able to stimulate rates of O 2 . production equivalent to SDS-initiated reactions, without the addition of other lipids species (e.g. DAG). The PA-mediated activation was not dependent on ATP, arguing against a role for a protein kinase in this system, and preincubation of reaction constituents with the phospholipid did not affect the kinetics or potency of the response. Cell-free NADPH oxidase systems do not completely duplicate events occurring in intact cells. For example, the lack of effect we observed with inhibitors of PKC on stimulation by DAG is consistent with the observation that most cell-free systems have no requirement for ATP or protein phosphorylation (58, 62) . This is in contrast to the intact cell, where protein phosphorylation is an important step in NADPH oxidase activation (18, 19) , and suggests that activation in cell extracts by SDS, arachidonate, or PAs/DAGs in this study is downstream of or bypasses the need to phosphorylate p47 phox . Cell-free activation probably also bypasses other steps in the signal transduction pathway and acts at the level of the enzyme itself.
Three properties of the system we describe here suggest that the activation mechanism involved is at least analogous to that operating in the intact phagocyte. First, in contrast to an earlier study (48) (see the Introduction), activation by either PAs or DAGs required the cytosolic components p47 phox and p67 phox and probably also Rac, since GTP was necessary. Second, many of the lipids we tested activated not only the fully soluble system, but also NADPH oxidase reactions in which membrane vesicles were the source of the membrane-bound flavocytochrome b 558 (see Table II ). Small amounts of deoxycholate are present in the reaction when detergent-solubilized membrane fractions are used, leaving open the possibility that a combination of the lipid agonist and the detergent are responsible for activating O 2 . generation. The ability of membrane vesicles to support PA or DAG-mediated activation in the absence of the solubilizing detergent circumvents this possibility. Third, in addition to the potent activation observed with synthetic DAG or PA containing a short chain fatty acid (e.g. dioctanoyl), PAs containing naturally occurring longer chain fatty acids were also active, in both the fully soluble and membrane vesiclecontaining system (e.g. dioleoyl-PA). Oleate is the most abundant fatty acid in the phosphatidate pool of resting and activated neutrophils, accounting for approximately one-third of the total fatty acid content (36) . Three biologically active forms of lipid, arachidonic acid, PA, and DAG, have now been shown to individually activate NADPH oxidase cell-free systems, with kinetics that match those observed in intact neutrophils. Of these lipid classes, which, if any, is likely to be a physiological stimulus? Data presented here indicate that, at least in the cell-free system, DAG activation of NADPH oxidase requires its conversion to PA, by the activity of an endogenous DAG kinase present in the cytosol. The link between the activity of this kinase and DAGstimulated O 2 . production, as demonstrated in Fig. 4 , strongly
implicates DAG-generated PA as the activating species in these cell-free assays. Although this is consistent with the translocation of activable DAG kinase in neutrophils stimulated with phorbol 12-myristate 13-acetate or fMLP (20) , it is important to point out that we are not proposing that the conversion of DAG to PA by DAG kinase is necessarily important in oxidase activation in the intact cell, only that it is the most likely explanation for our observations in the system used here. However, due to the likely existence of multiple signaling pathways for oxidase activation in vivo and its ability to synergize with PA, DAG cannot be ruled out as a candidate second messenger linked to the respiratory burst oxidase. Arachidonic acid is capable of stimulating O 2 . generation by intact cells (68) and in cell-free systems containing purified plasma membranes and cytosol (28 -31) . In addition, inhibitors of phospholipase A 2 block O 2 . generation (69, 70) . Despite this evidence, there are a number of reasons to believe that arachidonate does not act as the primary stimulus of NADPH oxidase. First, concentrations of arachidonate necessary for activation of the cell-free system (ϳ80 M) have not been demonstrated in stimulated whole neutrophils. (PA concentrations, on the other hand, can reach 50 -100 M in the stimulated neutrophil (34, 36) production under certain conditions, these phenomena are functionally independent (33, 72) . Finally, a recent report (73) provides good evidence that while arachidonate generated by cytosolic phospholipase A 2 is a necessary cofactor for NADPH oxidase, it does not provide the initial activating stimulus. This refutes the earlier suggestion that arachidonate is the immediate and sole stimulus of NADPH oxidase (69) . Thus, while it appears likely that arachidonate has a role in NADPH oxidase activation, there is evidence that it is not the predominant physiological activator. The amphiphilic structure of PA would appear to make it a good candidate for an agonist of a multicomponent, membranebound enzyme. Long, uncharged fatty acyl side chains may facilitate direct interaction with the phospholipid bilayer of the plasmalemma, serving to alter local membrane fluidity and structure. Similarly, the highly charged phosphate head groups could act as charge neutralizers, allowing the highly basic oxidase components (pI values for gp91 phox , p22 phox , and unphosphorylated p47 phox are 9.7, 10.0, and 9.5, respectively (74)) to come into close apposition. In turn, this could promote one or more of the potential specific interactions between the cytosolic and membrane-bound components (75) and lead to activation of the enzyme. A previous study has shown that a variety of biologically active lipids, including PA and arachidonic acid, are able to disrupt the ϳ50-kDa complex formed between Rac and RhoGDI (and that maintains Rac in a soluble form). This disruption appears to release Rac to participate in NADPH oxidase activation (76) . It is unlikely, however, that this is the sole mechanism of NADPH oxidase activation by PA, since recombinant cell-free systems in which Rac is added as the free, GTP-bound form still require the addition of a lipid activator.
The identification of the physiological signaling molecules that initiate and regulate phagocyte NADPH oxidase is central to our understanding of the mechanisms that control this enzyme. As major phospholipid pools responsive to neutrophil stimulation, the diglycerides and phosphatidic acids represent biologically relevant candidates for this role. In this study, we have shown for the first time that phosphatidate (added exogenously or derived from DAG) can independently activate NADPH oxidase in a cell-free system, suggesting that this lipid species could directly activate the enzyme in vivo.
